S*Bio Signs Two Major Anticancer Deals
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 1 (Table of Contents)
Published: 21 Jan-2009
DOI: 10.3833/pdr.v2009.i1.87 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
S*Bio, based in Singapore concluded two major deals for its anti-cancer drugs during January 2008; one with Onyx Pharmaceuticals for JAK2 inhibitors, SB1578 and SB1518, and the other with Tragara Pharmaceuticals for the oral multikinase inhibitor, SB1317...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS